Literature DB >> 12714251

A study of age-related IgE pathophysiological changes.

Gabriele Di Lorenzo1, Maria Luisa Pacor, Maria Esposito Pellitteri, Florinda Listì, Alfredo Colombo, Giuseppina Candore, Pasquale Mansueto, Claudia Lo Bianco, Vito Ditta, Giovanni Battista Rini, Calogero Caruso.   

Abstract

The literature on immunosenescence has focused mainly on T cell impairment. However, it is well known that B function is also profoundly affected. In particular, several studies have shown age-related changes in immunoglobulin serum levels. Concerning allergic diseases, the incidence of onset of allergic symptoms, as well as their severity, seems to decrease with age. So, the decline of onset of allergic symptoms observed in ageing might result from a decrease of serum total IgE due to an unbalance of cytokines and soluble factors involved in its production. To gain insight into the mechanisms of age related incidence of onset of allergic symptoms, as well as their severity, in this study we have evaluated in a sample of young (12 females and 15 males, range 20-64 years) and old (42 females and 20, males range 70-93 years) individuals serum values of IgE and sCD23 and in vitro Type 2 cytokine production. Total serum IgE levels were quantified by CAP-system fluorescence enzyme immunoassay. Serum CD23 levels were measured by a sandwich enzyme-linked immunoassay. Enzyme immunoassay tests have been used to quantify IL-4, IL-10 and IL-13 on mitogen-stimulated cultures. Serum total IgE and sCD23 in the two groups of young and old subjects were not significantly different. No detectable levels of IL-4, IL-10 and IL-13 were observed in supernatants from unstimulated cultures in all the subjects tested. After 48 h stimulation with PHA, cytokine amounts became detectable in all subjects. However, the values of the cytokines under study were not significantly different between young and old subjects. In our study, we have not been able to show no impairment in the afferent (type 2 cytokine production) and in the central (serum IgE and sCD23 levels) branch of allergic responses. Previous studies have shown that the efferent branch, at least studied as basophil releasability and bronchial responsiveness, is not impaired in elderly. In conclusion, as suggested from the present and previous papers it is questionable whether there is sufficient information to validate the statement that the incidence of allergic diseases decreases with age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714251     DOI: 10.1016/s0047-6374(03)00020-4

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  8 in total

1.  Clinical course of rhinitis and changes in vivo and in vitro of allergic parameters in elderly patients: a long-term follow-up study.

Authors:  Gabriele Di Lorenzo; Maria Stefania Leto-Barone; Simona La Piana; Vito Ditta; Gaetana Di Fede; Giovam Battista Rini
Journal:  Clin Exp Med       Date:  2012-02-04       Impact factor: 3.984

2.  Prevalence and clinical characteristics of allergic rhinitis in the elderly Korean population.

Authors:  Jae-Sung Nam; Chi-Sang Hwang; Min-Pyo Hong; Kyung-Su Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-02       Impact factor: 2.503

3.  Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patients with atopic dermatitis.

Authors:  Anja Mediaty; Karsten Neuber
Journal:  Immun Ageing       Date:  2005-05-31       Impact factor: 6.400

Review 4.  Immunological and non-immunological mechanisms of allergic diseases in the elderly: biological and clinical characteristics.

Authors:  Gabriele Di Lorenzo; Danilo Di Bona; Federica Belluzzo; Luigi Macchia
Journal:  Immun Ageing       Date:  2017-12-20       Impact factor: 6.400

Review 5.  Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.

Authors:  Maria Teresa Ventura; Nicola Scichilone; Roberto Paganelli; Paola Lucia Minciullo; Vincenzo Patella; Matteo Bonini; Giovanni Passalacqua; Carlo Lombardi; Livio Simioni; Erminia Ridolo; Stefano R Del Giacco; Sebastiano Gangemi; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2017-02-03

Review 6.  How to fit allergen immunotherapy in the elderly.

Authors:  Erminia Ridolo; Anti Rogkakou; Maria Teresa Ventura; Irene Martignago; Cristoforo Incorvaia; Gabriele Di Lorenzo; Giovanni Passalacqua
Journal:  Clin Mol Allergy       Date:  2017-10-06

7.  Diet Diversity Through the Life-Course as an Opportunity Toward Food Allergy Prevention.

Authors:  Giulia C I Spolidoro; Domenico Azzolino; Matteo Cesari; Carlo Agostoni
Journal:  Front Allergy       Date:  2021-09-24

Review 8.  Contraindications to immunotherapy: a global approach.

Authors:  C Pitsios; M Tsoumani; M B Bilò; G J Sturm; P Rodríguez Del Río; R Gawlik; F Ruëff; G Paraskevopoulos; E Valovirta; O Pfaar; M A Calderón; P Demoly
Journal:  Clin Transl Allergy       Date:  2019-09-11       Impact factor: 5.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.